SavedAdd your journal

Journals / Haydarpaşa Numune Medical Journal / 2018 / Cilt: 58 - Sayı: 4

Hepatotoxicity After Desflurane Anesthesia

Ekrem ASLAN
Can GÖNEN
Ayça SALTÜRK
Fatih GÜZELBULUT
Pages
224–226
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we present a case of severe transaminase elevation after using desflurane anesthesia for obesity surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Halogenated inhalational anesthetics, which have been used for the induction and maintenance of general anesthesia, can cause liver injury, ranging from temporary transaminase elevation to hepatic necrosis.
📊
Key Findings & Data:It is rare but causes serious morbidity and mortality.
💡
Conclusion & Impact:Herein we present a case of severe transaminase elevation after using desflurane anesthesia for obesity surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Halogenated inhalational anesthetics, which have been used for the induction and maintenance of general anesthesia, can cause liver injury, ranging from temporary transaminase elevation to hepatic necrosis. It is rare but causes serious morbidity and mortality. Herein we present a case of severe transaminase elevation after using desflurane anesthesia for obesity surgery.

🔖

Cite This Article

ASLAN, E., GÖNEN, C., SALTÜRK, A., GÜZELBULUT, F. (2018). Hepatotoxicity After Desflurane Anesthesia. Haydarpaşa Numune Medical Journal, Cilt: 58 - Sayı: 4, 224–226. https://ajindex.com/articles/197350

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Safari S, Motavaf M, Seyed Siamdoust SA, Alavian SM. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red Crescent Med J 2014;16:e20153. [CrossRef ] 2. Lin J, Moore D, Hockey B, Di Lernia R, Gorelik A, Liew D, et al. Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients. Liver Int 2014;34:576–82. [CrossRef ] 3. Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther 2010;17:219–22. [CrossRef] 4. Eghtesadi-Araghi P, Sohrabpour A, Vahedi H, Saberi-Firoozi M. Halothane hepatitis in Iran: a review of 59 cases. World J Gastroenterol. 2008 Sep 14;14:5322–6. [CrossRef ] 5. Walton B, Simpson BR, Strunin L, Doniach D, Perrin J, Appleyard AJ. Unexplained hepatitis following halothane. Br Med J 1976;1:1171–6. [CrossRef ] 6. Tung D, Yoshida EM, Wang CS, Steinbrecher UP. Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anaesth 2005;52:133–6. [CrossRef ] 7. Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM. Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis. Hepat Mon 2011;11:3–6. 8. Anderson JS, Rose NR, Martin JL, Eger EI, Njoku DB. Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies. Anesth Analg 2007;104:1452–3. [CrossRef ] 9. Lo SK, Wendon J, Mieli-Vergani G, Williams R. Halothaneinduced acute liver failure: continuing occurrence and use of liver transplantation. Eur J Gastroenterol Hepatol 1998;10:635–9. 10. Moore DH, Benson GD. Prolonged halothane hepatitis. Prompt resolution of severe lesion with corticosteroid therapy. Dig Dis Sci 1986;31:1269–72. [CrossRef ]